[
  {
    "ts": null,
    "headline": "BAX Stock Falls Following Q4 Earnings Miss, Margins Contract",
    "summary": "Baxter International misses Q4 EPS estimates as margins shrink, even as revenues top forecasts; shares slide 12.5% on weak 2026 guidance.",
    "url": "https://finnhub.io/api/news?id=9598665ae4a3968849017b746bba1fdb6755da06f3e45a69b9623eff1602b867",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770912180,
      "headline": "BAX Stock Falls Following Q4 Earnings Miss, Margins Contract",
      "id": 139067212,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Baxter International misses Q4 EPS estimates as margins shrink, even as revenues top forecasts; shares slide 12.5% on weak 2026 guidance.",
      "url": "https://finnhub.io/api/news?id=9598665ae4a3968849017b746bba1fdb6755da06f3e45a69b9623eff1602b867"
    }
  },
  {
    "ts": null,
    "headline": "INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands",
    "summary": "INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.",
    "url": "https://finnhub.io/api/news?id=75d4374f1c5a445b718a9b7a3bc070c4597f80aebaf1562de1597fd7b885f709",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770911640,
      "headline": "INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands",
      "id": 139067213,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.",
      "url": "https://finnhub.io/api/news?id=75d4374f1c5a445b718a9b7a3bc070c4597f80aebaf1562de1597fd7b885f709"
    }
  },
  {
    "ts": null,
    "headline": "AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline",
    "summary": "Avantor stock sinks 13% as Q4 earnings beat estimates, but revenues slip, margins contract and 2026 outlook signals more pressure ahead.",
    "url": "https://finnhub.io/api/news?id=c053eee6bc52bb209c6a25d7b8fcada3b349003f627fe0e98e3cff33127c4940",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770910860,
      "headline": "AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline",
      "id": 139067214,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Avantor stock sinks 13% as Q4 earnings beat estimates, but revenues slip, margins contract and 2026 outlook signals more pressure ahead.",
      "url": "https://finnhub.io/api/news?id=c053eee6bc52bb209c6a25d7b8fcada3b349003f627fe0e98e3cff33127c4940"
    }
  },
  {
    "ts": null,
    "headline": "QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down",
    "summary": "QDEL beats Q4 estimates as Labs and global growth lift sales, but shrinking margins and respiratory weakness weigh on profits.",
    "url": "https://finnhub.io/api/news?id=735e3111620d92fa0ec1670c5cb1e44628c44111ff9e04799270999e954e9878",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770906300,
      "headline": "QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down",
      "id": 139067215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "QDEL beats Q4 estimates as Labs and global growth lift sales, but shrinking margins and respiratory weakness weigh on profits.",
      "url": "https://finnhub.io/api/news?id=735e3111620d92fa0ec1670c5cb1e44628c44111ff9e04799270999e954e9878"
    }
  },
  {
    "ts": null,
    "headline": "Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down",
    "summary": "NVST shares jump 22% after Q4 EPS and revenue beat, with profits up 58% and double-digit segment growth despite gross margin pressure.",
    "url": "https://finnhub.io/api/news?id=29a183763416f9ce4dadde036c84684d9c13ea62bf4d11d25f539c93af5b5ad6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770906180,
      "headline": "Envista Stock Rises Post Q4 Earnings & Revenue Beat, Gross Margin Down",
      "id": 139060830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "NVST shares jump 22% after Q4 EPS and revenue beat, with profits up 58% and double-digit segment growth despite gross margin pressure.",
      "url": "https://finnhub.io/api/news?id=29a183763416f9ce4dadde036c84684d9c13ea62bf4d11d25f539c93af5b5ad6"
    }
  },
  {
    "ts": null,
    "headline": "PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up",
    "summary": "Prestige Consumer stock ticks higher as Q3 revenues top estimates, but EPS slips 7% and misses forecasts despite margin expansion.",
    "url": "https://finnhub.io/api/news?id=0f1acc2ce7e5216fcef1133b2c2783aa4c7bacab24e3a21f5cbeea823ea12133",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770905880,
      "headline": "PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up",
      "id": 139060831,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Prestige Consumer stock ticks higher as Q3 revenues top estimates, but EPS slips 7% and misses forecasts despite margin expansion.",
      "url": "https://finnhub.io/api/news?id=0f1acc2ce7e5216fcef1133b2c2783aa4c7bacab24e3a21f5cbeea823ea12133"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Inc (NYSE:CAH): A GARP Stock with Affordable Growth and Reasonable Valuation",
    "summary": "Cardinal Health (CAH) exemplifies the GARP strategy with solid growth, reasonable valuation, and a stable financial base, though low margins require attention.",
    "url": "https://finnhub.io/api/news?id=5109c7a51e01a2ce20bb65fb5589e06ce7abcef33116e8b594130726a8b3f002",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770888710,
      "headline": "Cardinal Health Inc (NYSE:CAH): A GARP Stock with Affordable Growth and Reasonable Valuation",
      "id": 139053787,
      "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
      "related": "CAH",
      "source": "ChartMill",
      "summary": "Cardinal Health (CAH) exemplifies the GARP strategy with solid growth, reasonable valuation, and a stable financial base, though low margins require attention.",
      "url": "https://finnhub.io/api/news?id=5109c7a51e01a2ce20bb65fb5589e06ce7abcef33116e8b594130726a8b3f002"
    }
  },
  {
    "ts": null,
    "headline": "The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call",
    "summary": "Cardinal Health’s fourth quarter was marked by robust top-line and profit growth, outpacing Wall Street expectations and prompting a positive market reaction. Management credited strong demand and execution in its pharmaceutical and specialty solutions segment as primary drivers, with CEO Jason Hollar noting, “Our strategic focus on specialty is delivering tangible results.” The company also cited double-digit profit growth across all five operating segments, highlighting the balanced performanc",
    "url": "https://finnhub.io/api/news?id=d53969962f0589425b32fd264692f6c7b559cbc4b610c9c36ab6068cf192e3f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770874627,
      "headline": "The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call",
      "id": 139053982,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health’s fourth quarter was marked by robust top-line and profit growth, outpacing Wall Street expectations and prompting a positive market reaction. Management credited strong demand and execution in its pharmaceutical and specialty solutions segment as primary drivers, with CEO Jason Hollar noting, “Our strategic focus on specialty is delivering tangible results.” The company also cited double-digit profit growth across all five operating segments, highlighting the balanced performanc",
      "url": "https://finnhub.io/api/news?id=d53969962f0589425b32fd264692f6c7b559cbc4b610c9c36ab6068cf192e3f0"
    }
  }
]